IDH1 and central nervous system cancer: Several studies from us and others have shown that DNMT1 inhibitors, decitabine (DAC) [36,37] and azacitidine (AZA) [38], exerts an antiproliferative tumor effect in vitro and in vivo in IDH1-mutant gliomas.